Platelet-activating factor modulates activity of cyclic nucleotides in fetal ovine pulmonary vascular smooth muscle

Journal of Pharmacology and Experimental Therapeutics

Volumn 320, Issue 2, 2007, Pages 728-737

  Ibe, Basil O ^a,b   Ameer, Adnan ^a   Portugal, Ada Mae ^a   Renteria, Lissette ^a   Raj, J Usha ^a  

^a HARBOR UCLA MEDICAL CENTER   (United States)

^b LOS ANGELES BIOMEDICAL RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC AMP; CYCLIC GMP; CYCLIC NUCLEOTIDE; INOSITOL 1,4,5 PHOSPHATE; PHOSPHATE; PROTEIN KINASE INHIBITOR; THROMBOCYTE ACTIVATING FACTOR; THROMBOCYTE ACTIVATING FACTOR RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DRUG INHIBITION; HYPOXIA; LUNG CIRCULATION; NONHUMAN; PRIORITY JOURNAL; VASCULAR SMOOTH MUSCLE;

8-BROMO CYCLIC ADENOSINE MONOPHOSPHATE; ANIMALS; CYCLIC AMP; CYCLIC AMP-DEPENDENT PROTEIN KINASES; CYCLIC GMP; CYCLIC GMP-DEPENDENT PROTEIN KINASES; FEMALE; FETUS; INOSITOL 1,4,5-TRISPHOSPHATE; LUNG; MUSCLE, SMOOTH, VASCULAR; PLATELET ACTIVATING FACTOR; PLATELET MEMBRANE GLYCOPROTEINS; PREGNANCY; RECEPTORS, G-PROTEIN-COUPLED; SHEEP;

EID: 33846451399     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.106.111914     Document Type: Article

References (40)

1. Abdel-Latif AA (2001) Cross talk between cyclic nucleotides and polyphosphoinositide hydrolysis, protein kinases, and contraction in smooth muscle. Exp Biol Med 226:153-163.
2. Ali H, Richardson RM, Tomhave ED, Dubose RA, Haribabu B, and Snyderman R (1994) Regulation of stably transfected platelet activating factor receptor in RBL-2H3 cells. J Biol Chem 269:24557-24563.
3. Argiolas L, Fabi F, and del Basso P (1995) Mechanisms of pulmonary vasoconstriction and bronchoconstriction produced by PAF in guinea-pig: role of platelets and cyclo-oxygenase metabolites. Br J Pharmacol 114:203-209.
4. Block KD, Filippov G, Sanchez LS, Nakane M, and de la Monte SM (1997) Pulmonary soluble guanylate cyclase, a nitric oxide receptor, is increased during the perinatal period. Am J Physiol 272:L400-L406.
5. Caplan MS, Hsueh W, Sun X-M, Gidding SS, and Hageman JR (1990) Circulating plasma PAF in persistent pulmonary hypertension of the newborn. Am Rev Respir Dis 142:1258-1262.
6. Carlson SA, Chatterjee TK, and Fisher RA (1996) The third intracellular domain of the platelet-activating factor receptor is critical determinant in the receptor coupling to phosphoinositide phospholipase C activating G proteins. J Biol Chem 272:23146-23153.
7. Dhanakoti SN, Gao Y, Nguyen MQ, and Raj JU (2000) Involvement of cGMP-dependent protein kinase in the relaxation of ovine pulmonary arteries to cGMP and cAMP. J Appl Physiol 88:1637-1642.
8. Evgenov OV, Ichinose F, Evgenov NV, Gnoth MJ, Falkowski GE, Chang Y, Bloch KD, and Zapol WM (2004) Soluble guanylate cyclase activator reverses acute pulmonary hypertension and augments the pulmonary vasodilator response to inhaled nitric oxide in awake lambs. Circulation 110:2253-2259.
9. Ferguson SSG, Barak LS, Zhang J, and Caron MG (1996) G protein-coupled receptor regulation: role of G protein-coupled receptor kinases and arrestins. Can J Physiol Pharmacol 74:1095-1110, 1996.
10. Fineman JR, Soifer SJ, and Heymann MA (1995) Regulation of pulmonary vascular tone in the perinatal period. Annu Rev Physiol 57:115-134.
11. Fratz S, Meyrick B, Ovadia B, Johengen M, Reinhart O, Azakie A, Ross G, Fitzgerald R, Oishi P, Hess J, et al. (2004) Chronic endothelin A receptor blockade in lambs with increased pulmonary blood flow and pressure. Am J Physiol 287:L592-L597.
12. Gao Y, Dhanakoti S, Trevino EM, Wang X, Sander FC, Portugal AM, and Raj JU (2004) Role of cGMP-dependent protein kinase in development of tolerance to nitric oxide in pulmonary veins of newborn lambs. Am J Physiol 286:L786-L792.
13. Gao Y, Zhou H, and Raj JU (1995) Heterogeneity in role of endothelium-derived NO in pulmonary arteries and veins of full term fetal lambs. Am J Physiol 268:H1586-H1592.
14. Gilman AG (1995) G-proteins and regulation of adenylyl cyclase. Biosci Rep 15:65-97.
15. Heymann MA, Creasy RK, and Rudolph AM (1990) Quantitation of blood flow patterns in fetal lamb in utero, in Proceedings of the Sir Bancroft Symposium: Foetal and Neonatal Physiology, p 129, Cambridge University Press, Cambridge, UK.
16. Hicks JK, Bahn Y-S, and Heitman J (2005) Pde1 phosphodiesterase modulates cyclic AMP levels through a protein kinase A-mediated negative feedback loop in Cryptococcus neoformans. Eukaryot Cell 4:1971-1981.
17. Ibe BO, Hibler S, and Raj JU (1998) Platelet-activating factor modulates pulmonary vasomotor tone in the perinatal lamb. J Appl Physiol 85:1079-1085.
18. Ibe BO, Portugal AM, Chaturvedi S, and Raj JU (2005) Oxygen-dependent PAF receptor binding and intracellular signaling in ovine fatal pulmonary vascular smooth muscle. Am J Physiol 288:L879-L886.
19. 2 protein expression and activities of acetyl-CoA acetyltransferase and cholinephosphotransferase. Mol Genet Metab 77:237-248.
20. Ibe BO, Sander FC, and Raj JU (2002) Platelet-activating factor receptors in lamb lungs are down-regulated immediately after birth. Am J Physiol 278:H1168-H1176, 2000.
21. Ignarro LJ (1990) Biosynthesis and metabolism of endothelium-derived nitric oxide. Annu Rev Pharmacol Toxicol 30:535-560, 1990.
22. Johnson JA and Barman SA (2004) Protein kinase C modulation of cyclic GMP in rat neonatal pulmonary vascular smooth muscle cell. Lung 182:79-89.
23. Kääpä P, Raj JU, Ibe BO, and Anderson J (1991) Effect of pentoxifylline in rabbit pulmonary circulation: influence of age and vasomotor tone. Am J Physiol 261:H975-H981.
24. Kim JD, Baker CJ, Roberts RF, Darbinian SH, Marcus KA, Quardt SM, Starnes VA, and Barr ML (2000) Platelet activating factor acetylhydrolase decreases lung perfusion injury. Ann Thorac Surg 70:423-428.
25. Korth RM, Hirafuji M, Benveniste J, and Russo-Marie F (1995) Human umbilical vein endothelial cell: specific binding of platelet-activating factor and cytosolic calcium flux. Biochem Pharmacol 49:1703-1799.
26. Kudej RK, Zhang X-P, Ghaleh B, Huang C-H, Jackson JB, Kudej AB, Sato N, Sato S, Vatner DE, Hintze TH, et al. (2000) Enhanced cAMP-induced nitric oxide-dependent coronary dilation during myocardial stunning in conscious pigs. Am J Physiol 279:H2967-H2974.
27. Lee J-H, Johnson PRA, Roth M, Hunt NH, and Black JL (2001) ERK activation and mitogenesis in human airway smooth muscle cells. Am J Physiol 280:L1019-L1029.
28. Lin A-Y and Rui Y-C (1994) Platelet activating factor induced calcium mobilization and phosphoinositide metabolism in cultured cerebral microvascular endothelial cells. Biochim Biophys Acta 1224:323-328.
29. Millard SL, Russell JA, Morin FC III, Adolf MA, Gugino SF, and Steinhorn RH (1998) cGMP inhibition of endothelin-stimulated inositol phosphate production in fetal lamb pulmonary artery. Pulmunol Pharmacol Ther 11:201-204.
30. Milligan G and Kostenis E (2006) Heterotrimeric G-proteins: a short history. Br J Pharmacol 147:S46-S55.
31. Nakahara T, Yunoki M, Moriuchi H, Mitani A, and Sakamoto K (2002) Relaxation and potentiation of cGMP-mediated response by ibudilast in bovine tracheal smooth muscle. Naunyn-Schmeideberg's Arch Pharmacol 366:262-269.
32. Nambi P, Whitman M, Aiyar N, Stassen F, and Crooke ST (1987) An activator of protein kinase C (phorbol dibutyrate) attenuates atrial-natriuretic factor-stimulated cyclic GMP accumulation in smooth muscle cells. Biochem J 244:481-484.
33. Orton EC, Raffestin B, and McMurtry IF (1990) Protein kinase C influences rat pulmonary vascular reactivity. Am Rev Respir Dis 141:654-658.
34. Parent J-L, Le Gouill C, Escher E, Rola-Pleszcynski M, and Stankova J (1996) Identification of transmembrane domain residues determinant in the structure-function relationship of human platelet-activating factor receptor by site directed mutagenesis. J Biol Chem 271:23298-23303.
35. Ray CJ and Marshall JM (2006) The cellular mechanisms by which adenosine evokes release of nitric oxide from rat aortic endothelium. J Physiol (Lond) 570:85-96.
36. Rehring TF, Brew EC, Friese RS, Banerjee A, and Harken AH (1996) Clinically accessible cell signaling: second messengers in sepsis and trauma. J Surg Res 60:270-277.
37. Stafforini DM, McIntyre TM, Zimmerman GA, and Prescott SM (2003) Platelet-activating factor, a pleiotrophic mediator of physiological and pathological processes. Crit Rev Clin Lab Sci 40:643-672.
38. Standaert ML, Galloway L, Karnam P, Badyopadhyay G, Moscal J, and Farese RV (1997) Protein kinase C-ζ as a downstream effector of phosphatidylinositol 3-kinase during insulin stimulation in rat adipocytes. J Biol Chem 272:30075-30082.
39. Taylor CT, Lisco SJ, Awtrey CS, and Colgan SP (1998) Hypoxia inhibits cyclic nucleotide-stimulated epithelial ion transport: role for nucleotide cyclases as oxygen sensors. J Pharmacol Exp Ther 28:568-575.
40. Toga H, Hibler S, Ibe BO, and Raj JU (1992) Vascular effects of platelet-activating factor in lambs: role of cyclo- and lipoxygenase J Appl Physiol 73:2559-2566.